New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XHSvsBBPETF Comparison

ETF 1
XHS

SPDR S&P Health Care Services ETF

This fund is part of
US Health Care
-0.31%
Full XHS fund page
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-0.38%
Full BBP fund page

SPDR S&P Health Care Services ETF (XHS) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.79% for BBP. XHS is down -1.75% year-to-date (YTD) with +$6M in YTD flows. BBP performs better with 6.54% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of XHS and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHS vs BBP performance and flow charts

Performance

-2.00.02.04.06.0%Feb 10Feb 18Feb 25Mar 4Mar 11

Cumulative Flows

-8 M-6 M-4 M-2 M0 M2 M4 MFeb 10Feb 18Feb 25Mar 4Mar 11

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
XHS
BBP
-3.11%+3.49%
-3.76%+9.58%
-1.75%+6.54%
+10.69%+42.80%
+26.75%+83.49%
-0.05%+60.18%
Flows
XHS
BBP
-$8M+$4M
+$2M+$16M
+$6M+$4M
-$3M+$19M
-$34M+$19M
-$36M+$9M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHS
BBP
+17.45%+24.65%
+19.20%+25.47%
+18.15%+23.56%
+21.12%+26.14%
Max drawdown
XHS
BBP
-6.02%-7.42%
-12.54%-17.97%
-17.78%-25.54%
-32.53%-38.24%
Max drawdown duration
XHS
BBP
64d32d
128d106d
362d292d
1717d915d
Trading data

Create an account to view trading data

Join for free
XHS
BBP
Last sale
3/12/2026 at 1:30 PM
$103.05
$81.68
Previous close
03/11/2026
$104.90
$84.32
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHS
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
XHS
BBP
Last price
$103.05
$81.68
1D performance
-1.76%
-3.13%
AuM$87.16 M$50.98 M
E/R0.35%0.79%
Characteristics
XHS
BBP
Management strategyPassivePassive
ProviderSPDRVIRTUS Investment Partners
BenchmarkS&P Health Care Services Select Industry IndexLifeSci Biotechnology Products Index
N° of holdings5258
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 28, 2011December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

XHS
USA
99.96%
Other
0.04%
BBP
USA
90.82%
Other
9.18%

Sectors

XHS
Health Care
87.38%
Other
12.62%
BBP
Health Care
88.88%
Other
11.12%
Advertisement

Diversification

XHS

Total weight of top 15 holdings out of 15

33.22%
BBP

Total weight of top 15 holdings out of 15

30.11%

Top 15 holdings

Data as of January 31, 2026
XHS
BROOKDALE SENIOR LIVING
2.87%
ALIGNMENT HEALTHCARE
2.39%
US20603L1026
2.27%
CENTENE
2.25%
MOLINA HLTHCRE
2.24%
US10950A1060
2.24%
GUARDANT HEALTH INC
2.23%
CARDINAL HEALTH
2.17%
AMERISOURCEBERGEN
2.11%
CIGNA
2.09%
HCA HEALTHCARE
2.09%
QUEST DIAGNOSTICS
2.09%
US5049221055
2.08%
OPTION CARE HEALTH INC
2.06%
MCKESSON
2.04%
BBP
DAY ONE BIOPHARMACEUTICALS
2.39%
DYNAVAX TECHNOLOGIES
2.39%
AMICUS THERAPEUTICS
2.25%
IOVANCE BIOTHERAPEUTICS INC
2.18%
ARDELYX
2.09%
AXSOME THERA CMN STK
2.07%
BIONTECH SE ADR
2.07%
GILEAD SCIENCES
1.90%
KRYSTAL BIOTECH INC
1.89%
HALOZYME THERAPEUTICS
1.86%
US52635N1037
1.85%
AMGEN-T
1.83%
THERAVANCE BIOPHARMA
1.80%
INCYTE
1.78%
EXELIXIS
1.77%
Frequently asked questions about XHS and BBP

How have the XHS and BBP ETFs performed in 2026?

As of March 11, 2026, XHS is down -1.75% year-to-date (YTD), while BBP has returned 6.54%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: XHS or BBP?

Year-to-date, the XHS ETF saw +$6M in flows, compared to +$4M for BBP.

Which ETF is more volatile: XHS or BBP?

Over the past year, XHS had a volatility of 19.2%, while BBP experienced 25.47%.

Which ETF is bigger: XHS or BBP?

As of March 11, 2026, XHS holds $87.16 M in assets under management (AUM), while BBP manages $50.98 M.

What sectors do the XHS and BBP ETFs invest in?

XHS leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the XHS ETF and BBP ETF?

XHS top holdings include BROOKDALE SENIOR LIVING, ALIGNMENT HEALTHCARE and US20603L1026. BBP holds in its top three: DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS.

Which ETF is more diversified: XHS or BBP?

XHS holds 59 securities with 33.22% of its assets in the top 15. BBP has 63 securities and a top 15 weight of 30.11%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast